tiprankstipranks
Trending News
More News >
InMed Pharmaceuticals (INM)
NASDAQ:INM
Advertisement

InMed Pharmaceuticals (INM) Revenue

Compare
381 Followers

InMed Pharmaceuticals Revenue

InMed Pharmaceuticals had a revenue of 4.94B in the quarter ending Jun 30, 2025, with 274722.04%. This bring the company's revenue in the last twelve months to 4.94B, Decreased 71883.32%. In the fiscal year ending Dec 31, 2025, InMed Pharmaceuticals had annual revenue of 4.94B with 78504.30% growth.
Revenue (ttm)
4.94B
Revenue Growth
7.50%
P/S Ratio
<0.01
Revenue/Employee
$380,202,538
Employees
13
Market Cap
$5.22M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
4.94B4.94B+78,604.31%
Dec 31, 2024
6.29M809.35K+114.77%
Dec 31, 2023
5.48M4.08M+390.57%
Dec 31, 2022
1.40M-140,272,500.00%
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis